Stocks and Investing Stocks and Investing
Fri, April 5, 2019
Thu, April 4, 2019
Wed, April 3, 2019

Andrew Berens Initiated (BPMC) at Buy and Held Target at $112 on, Apr 3rd, 2019


Published on 2024-10-26 12:53:57 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of Morgan Stanley, Initiated "Blueprint Medicines Corporation" (BPMC) at Buy and Held Target at $112 on, Apr 3rd, 2019.

Andrew, nor any peers, have made any analyst calls on BPMC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources